Semaglutide 0.25 mg

DRUG3 trials

Sponsors

University Health Network, Toronto, Chinese University of Hong Kong, University of Ulster

Conditions

Cardiovascular DiseaseKidney Transplant RecipientOmega-3 Fatty AcidsPsoriasis ArthritisType 2 Diabetes

Phase 2

Semaglutide for the Prevention Of Post-Transplant Diabetes Mellitus

Not yet recruitingNCT06913023

University Health Network, TorontoKidney Transplant Recipient

Start: 2026-09-05End: 2029-12-30Target: 37Updated: 2026-09-16

Phase 4

GLP-1 Receptor Agonists in Non-diabetic Patients With Psoriatic Arthritis

Not yet recruitingNCT07251556

Chinese University of Hong KongPsoriasis Arthritis

Start: 2025-12-01End: 2027-01-01Target: 40Updated: 2025-12-02

Unknown Phase

Free Fatty Acid Effects In Type 2 Diabetes

Enrolling by invitationNCT07677995

University of UlsterCardiovascular Disease, Omega-3 Fatty Acids, Type 2 Diabetes

Start: 2026-09-01End: 2027-02-01Target: 60Updated: 2026-09-01